Document Type : Original Article(s)


1 Associate Professor, Cardiovascular Diseases Research Center AND Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

2 Professor, Cardiovascular Diseases Research Center AND Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

3 Assistant Professor, Cardiovascular Diseases Research Center AND Department of Cardiology, Heshmat Hospital, School of Medicine AND Research Center of Health and Environment, School of Health, Guilan University of Medical Sciences, Rasht, Iran

4 Cardiovascular Diseases Research Center AND Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran


BACKGROUND: Depression is closely related to coronary artery disease (CAD). However, the association of depression before angiography with major adverse cardiovascular event (MACE) is still unknown.METHODS: In a prospective cohort study, 410 patients underwent angiography for the first time between 2016 and 2017 in Dr. Heshmat Hospital, Rasht, Iran. Demographic and medical information were collected and depressive symptoms were assessed using Beck Depression Inventory-II (BDI-II). The patients were followed for one year after angiography. Chi-square test and analysis of variance (ANOVA) were performed to compare demographic and clinical characteristics of patients between different levels of depressive symptoms. Multiple Cox regression analysis was performed to assess the association between depression symptoms before angiography and MACE rate controlled for the effect of confounders.RESULTS: Of 410 patients, follow-up data were available for 380 (95%) patients. the MACE occurred in 134 (35%) patients. Depressive symptoms were observed in 42% of patients. Based on multivariable Cox regression analysis, adjusted for CAD severity, the risk of one-year MACE occurrence in patients with mild, moderate, and severe depressive symptoms was 1.96 [95% confidence interval (CI) for hazard ratio (HR): 1.30-2.94], 1.88 (95% CI for HR: 1.15-3.09), and 2.81 (95% CI for HR: 1.56-5.06) times that of patients without depressive symptoms, respectively. Depression in patients before angiography increased the risk of MACE up to 2.045 times.CONCLUSION: The results showed that MACE in patients with depression was more than patients without depression. MACE in different levels of depression (mild, moderate, severe) was not significantly different.


  1. Connerney I, Sloan RP, Shapiro PA, Bagiella E, Seckman C. Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med 2010; 72(9): 874-81.
  2. Damen NL, Versteeg H, Boersma E, Serruys PW, van Geuns RJ, Denollet J, et al. Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: Results from the RESEARCH registry. Int J Cardiol 2013; 167(6): 2496-501.
  3. Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: A meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011; 33(3): 203-16.
  4. Zuidersma M, Conradi HJ, van Melle JP, Ormel J, de Jonge P. Self-reported depressive symptoms, diagnosed clinical depression and cardiac morbidity and mortality after myocardial infarction. Int
  5. J Cardiol 2013; 167(6): 2775-80.
  6. Murphy B, Rogerson M, Worcester M, Elliott P, Higgins R, Le Grande M, et al. Predicting mortality 12 years after an acute cardiac event: Comparison between inhospital and 2-month assessment of depressive symptoms in women. J Cardiopulm Rehabil Prev 2013; 33(3): 160-7.
  7. Elderon L, Whooley MA. Depression and cardiovascular disease. Prog Cardiovasc Dis 2013; 55(6): 511-23.
  8. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364(9438): 937-52.
  9. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment. Psychosom Med 2004; 66(3): 305-15.
  10. Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, de JP, Davidson KW, et al. History of depression and survival after acute myocardial infarction. Psychosom Med 2009; 71(3): 253-9.
  11. Parakh K, Thombs BD, Fauerbach JA, Bush DE, Ziegelstein RC. Effect of depression on late (8 years) mortality after myocardial infarction. Am J Cardiol 2008; 101(5): 602-6.
  12. Myers V, Gerber Y, Benyamini Y, Goldbourt U, Drory Y. Post-myocardial infarction depression: Increased hospital admissions and reduced adoption of secondary prevention measures-a longitudinal study. J Psychosom Res 2012; 72(1): 5-10.
  13. Reese RL, Freedland KE, Steinmeyer BC, Rich MW, Rackley JW, Carney RM. Depression and rehospitalization following acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2011; 4(6): 626-33.
  14. Sullivan MD, LaCroix AZ, Spertus JA, Hecht J, Russo J. Depression predicts revascularization procedures for 5 years after coronary angiography. Psychosom Med 2003; 65(2): 229-36.
  15. Park MW, Kim JH, Her SH, Cho JS, Choi MS, Gweon TG, et al. Effects of percutaneous coronary intervention on depressive symptoms in chronic stable angina patients. Psychiatry Investig 2012; 9(3): 252-6.
  16. Hance M, Carney RM, Freedland KE, Skala J. Depression in patients with coronary heart disease. A 12-month follow-up. Gen Hosp Psychiatry 1996; 18(1): 61-5.
  17. Tsai IT, Wang CP, Lu YC, Hung WC, Wu CC, Lu LF, et al. The burden of major adverse cardiac events in patients with coronary artery disease. BMC Cardiovasc Disord 2017; 17(1): 1.
  18. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996
  19. Beck At, Ward Ch, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
  20. Wang ZJ, Guo M, Si TM, Jiang MM, Liu SM, Liu YY, et al. Association of depression with adverse cardiovascular events after percutaneous coronary intervention. Coron Artery Dis 2013; 24(7): 589-95.
  21. Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a Persian-language version of the Beck Depression Inventory-Second edition: BDI-II-PERSIAN. Depress Anxiety 2005; 21(4): 185-92.
  22. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993; 270(15): 1819-25.
  23. Li XM, Li TT, Cong HL, Guo ZG, Song JH, Zhao R, et al. Impact of depression on prognosis of patients with coronary heart disease undergoing revascularization. Zhonghua Xin Xue Guan Bing Za Zhi 2012; 40(2): 99-103.
  24. Frasure-Smith N, Lesperance F, Irwin MR, Sauve C, Lesperance J, Theroux P. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes. Biol Psychiatry 2007; 62(4): 302-8.
  25. Meyer T, Hussein S, Lange HW, Herrmann-Lingen C. Anxiety is associated with a reduction in both mortality and major adverse cardiovascular events five years after coronary stenting. Eur J Prev Cardiol 2015; 22(1): 75-82.
  26. Rothenbacher D, Hahmann H, Wusten B, Koenig W, Brenner H. Symptoms of anxiety and depression in patients with stable coronary heart disease: Prognostic value and consideration of pathogenetic links. Eur J Cardiovasc Prev Rehabil 2007; 14(4): 547-54.
  27. Shibeshi WA, Young-Xu Y, Blatt CM. Anxiety worsens prognosis in patients with coronary artery disease. J Am Coll Cardiol 2007; 49(20): 2021-7.
  28. Pelletier R, Bacon SL, Arsenault A, Dupuis J, Laurin C, Blais L, et al. Relative associations between depression and anxiety on adverse cardiovascular events: Does a history of coronary artery disease matter? A prospective observational study. BMJ Open 2015; 5(12): e006582.
  29. Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: Epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol 2013; 2013: 695925.